These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23062550)

  • 1. Synthesis and biological characterization of a series of novel diaryl amide M₁ antagonists.
    Poslusney MS; Sevel C; Utley TJ; Bridges TM; Morrison RD; Kett NR; Sheffler DJ; Niswender CM; Daniels JS; Conn PJ; Lindsley CW; Wood MR
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6923-8. PubMed ID: 23062550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and SAR of N-(4-(4-alklylpiperazin-1-yl)phenyl)benzamides as muscarinic acetylcholine receptor subtype 1 (M1) anatgonists.
    Miller NR; Daniels RN; Lee D; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2174-7. PubMed ID: 20202841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First structure-activity relationship study on dopamine D3 receptor agents with N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamide structure.
    Leopoldo M; Lacivita E; Colabufo NA; Contino M; Berardi F; Perrone R
    J Med Chem; 2005 Dec; 48(25):7919-22. PubMed ID: 16335915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a methoxynaphthalene scaffold as a core replacement in quinolizidinone amide M(1) positive allosteric modulators.
    Kuduk SD; Di Marco CN; Saffold JR; Ray WJ; Ma L; Wittmann M; Koeplinger KA; Thompson CD; Hartman GD; Bilodeau MT; Beshore DC
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1417-20. PubMed ID: 24485781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learning.
    Sheffler DJ; Williams R; Bridges TM; Xiang Z; Kane AS; Byun NE; Jadhav S; Mock MM; Zheng F; Lewis LM; Jones CK; Niswender CM; Weaver CD; Lindsley CW; Conn PJ
    Mol Pharmacol; 2009 Aug; 76(2):356-68. PubMed ID: 19407080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of benzodioxanylpiperazine derivatives as potent serotonin 5-HT(1A) antagonists: the discovery of Lecozotan.
    Childers WE; Abou-Gharbia MA; Kelly MG; Andree TH; Harrison BL; Ho DM; Hornby G; Huryn DM; Potestio L; Rosenzweig-Lipson SJ; Schmid J; Smith DL; Sukoff SJ; Zhang G; Schechter LE
    J Med Chem; 2005 May; 48(10):3467-70. PubMed ID: 15887953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of LY593093, an M1 muscarinic acetylcholine receptor-selective partial orthosteric agonist.
    Watt ML; Schober DA; Hitchcock S; Liu B; Chesterfield AK; McKinzie D; Felder CC
    J Pharmacol Exp Ther; 2011 Aug; 338(2):622-32. PubMed ID: 21558436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse engineering of the selective agonist TBPB unveils both orthosteric and allosteric modes of action at the M₁ muscarinic acetylcholine receptor.
    Keov P; Valant C; Devine SM; Lane JR; Scammells PJ; Sexton PM; Christopoulos A
    Mol Pharmacol; 2013 Sep; 84(3):425-37. PubMed ID: 23798605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of [(2,3-dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as novel ligands selective for the dopamine D3 receptor subtype.
    Robarge MJ; Husbands SM; Kieltyka A; Brodbeck R; Thurkauf A; Newman AH
    J Med Chem; 2001 Sep; 44(19):3175-86. PubMed ID: 11543687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-(2-alkylaminoethyl)-4-(1,2,4-oxadiazol-5-yl)piperazine-1-carboxamides as highly potent smoothened antagonists.
    Muraglia E; Ontoria JM; Branca D; Dessole G; Bresciani A; Fonsi M; Giuliano C; Llauger Bufi L; Monteagudo E; Palumbi MC; Torrisi C; Rowley M; Steinkühler C; Jones P
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5283-8. PubMed ID: 21802943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel isoxazole carboxamides as growth hormone secretagogue receptor (GHS-R) antagonists.
    Liu B; Liu G; Xin Z; Serby MD; Zhao H; Schaefer VG; Falls HD; Kaszubska W; Collins CA; Sham HL
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5223-6. PubMed ID: 15380232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of the first potent, selective 5-hydroxytryptamine1D receptor antagonist.
    Ward SE; Harrington FP; Gordon LJ; Hopley SC; Scott CM; Watson JM
    J Med Chem; 2005 May; 48(10):3478-80. PubMed ID: 15887956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orthosteric and allosteric modes of interaction of novel selective agonists of the M1 muscarinic acetylcholine receptor.
    Avlani VA; Langmead CJ; Guida E; Wood MD; Tehan BG; Herdon HJ; Watson JM; Sexton PM; Christopoulos A
    Mol Pharmacol; 2010 Jul; 78(1):94-104. PubMed ID: 20413650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of xanomeline analogs--probing the wash-resistant phenomenon at the M1 muscarinic acetylcholine receptor.
    Kane BE; Grant MK; El-Fakahany EE; Ferguson DM
    Bioorg Med Chem; 2008 Feb; 16(3):1376-92. PubMed ID: 17977730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-alkyl-4-acylpiperazines as a new class of imidazole-free histamine H(3) receptor antagonists.
    Zaragoza F; Stephensen H; Knudsen SM; Pridal L; Wulff BS; Rimvall K
    J Med Chem; 2004 May; 47(11):2833-8. PubMed ID: 15139761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-4-t-Butylbenzyl 2-(4-methylsulfonylaminophenyl) propanamide TRPV1 antagonists: Structure-activity relationships in the A-region.
    Kim YS; Kil MJ; Kang SU; Ryu H; Kim MS; Cho Y; Bhondwe RS; Thorat SA; Sun W; Liu K; Lee JH; Choi S; Pearce LV; Pavlyukovets VA; Morgan MA; Tran R; Lazar J; Blumberg PM; Lee J
    Bioorg Med Chem; 2012 Jan; 20(1):215-24. PubMed ID: 22169633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules.
    Hern JA; Baig AH; Mashanov GI; Birdsall B; Corrie JE; Lazareno S; Molloy JE; Birdsall NJ
    Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2693-8. PubMed ID: 20133736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the binding site of novel selective positive allosteric modulators at the M
    Khajehali E; Valant C; Jörg M; Tobin AB; Conn PJ; Lindsley CW; Sexton PM; Scammells PJ; Christopoulos A
    Biochem Pharmacol; 2018 Aug; 154():243-254. PubMed ID: 29777683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of piperazine derivatives as 5-HT7 receptor antagonists.
    Yoon J; Yoo EA; Kim JY; Pae AN; Rhim H; Park WK; Kong JY; Park Choo HY
    Bioorg Med Chem; 2008 May; 16(10):5405-12. PubMed ID: 18456500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptor.
    Abdul-Ridha A; López L; Keov P; Thal DM; Mistry SN; Sexton PM; Lane JR; Canals M; Christopoulos A
    J Biol Chem; 2014 Feb; 289(9):6067-79. PubMed ID: 24443568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.